Autosomal dominant generalized epidermolysis bullosa simplex, severe form Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Sep 2025A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

BioMendics, LLC — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Autosomal dominant generalized epidermolysis bullosa simplex, severe form.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1Phase 2

1Total recruiting

Search clinical trials for Autosomal dominant generalized epidermolysis bullosa simplex, severe form →

Recent News & Research

No recent news articles indexed yet for Autosomal dominant generalized epidermolysis bullosa simplex, severe form.
Search PubMed for Autosomal dominant generalized epidermolysis bullosa simplex, severe form →

Browse all Autosomal dominant generalized epidermolysis bullosa simplex, severe form news →

Specialist Network

No specialists currently listed for Autosomal dominant generalized epidermolysis bullosa simplex, severe form.

View all Autosomal dominant generalized epidermolysis bullosa simplex, severe form specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰